Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.

Hudes GR, Carducci MA, Choueiri TK, Esper P, Jonasch E, Kumar R, Margolin KA, Michaelson MD, Motzer RJ, Pili R, Roethke S, Srinivas S.

J Natl Compr Canc Netw. 2011 Feb;9 Suppl 1:S1-29.

2.

Challenging the treatment paradigm for advanced renal cell carcinoma: a review of systemic and localized therapies.

Bex A, Larkin J, Voss M.

Am Soc Clin Oncol Educ Book. 2015:e239-47. doi: 10.14694/EdBook_AM.2015.35.e239. Review.

3.

Circulating biomarkers in advanced renal cell carcinoma: clinical applications.

Hernandez-Yanez M, Heymach JV, Zurita AJ.

Curr Oncol Rep. 2012 Jun;14(3):221-9. doi: 10.1007/s11912-012-0231-2. Review.

4.

Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.

Bex A, Gore M, Mulders P, Sternberg CN.

BJU Int. 2012 Nov;110(9):1289-300. doi: 10.1111/j.1464-410X.2012.11100.x. Epub 2012 Mar 30. Review.

5.

Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualization.

Garcia-Donas J, Rodriguez-Moreno JF, Romero-Laorden N, Rodriguez-Antona C.

Urol Oncol. 2015 Apr;33(4):179-86. doi: 10.1016/j.urolonc.2013.09.015. Epub 2014 Feb 1. Review.

PMID:
24495452
6.

Systemic therapies for metastatic renal cell carcinoma in older adults.

Pal SK, Vanderwalde A, Hurria A, Figlin RA.

Drugs Aging. 2011 Aug 1;28(8):635-49. doi: 10.2165/11592880-000000000-00000. Review.

7.

Targeted therapy of kidney cancer: keeping the art around the algorithms.

Fishman MN.

Cancer Control. 2013 Jul;20(3):222-32. Review.

8.

Metastatic renal cell carcinoma: many treatment options, one patient.

Rini BI.

J Clin Oncol. 2009 Jul 1;27(19):3225-34. doi: 10.1200/JCO.2008.19.9836. Epub 2009 May 26. Review.

PMID:
19470934
9.

Targeted therapies for non-clear renal cell carcinoma.

Singer EA, Bratslavsky G, Linehan WM, Srinivasan R.

Target Oncol. 2010 Jun;5(2):119-29. doi: 10.1007/s11523-010-0148-3. Epub 2010 Aug 3. Review.

10.

Aerobic glycolysis: a novel target in kidney cancer.

Shuch B, Linehan WM, Srinivasan R.

Expert Rev Anticancer Ther. 2013 Jun;13(6):711-9. doi: 10.1586/era.13.57. Review.

11.

Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review.

Yin M, Wang W, Rosenberg J, Kaag M, Joshi M, Holder S, Tuanquin L, Drabick JJ.

Clin Genitourin Cancer. 2016 Apr;14(2):e203-6. doi: 10.1016/j.clgc.2015.11.008. Epub 2015 Nov 17. Review. No abstract available.

PMID:
26684811
12.

How to select targeted therapy in renal cell cancer.

Escudier B, Albiges L, Blesius A, Loriot Y, Massard C, Fizazi K.

Ann Oncol. 2010 Oct;21 Suppl 7:vii59-62. doi: 10.1093/annonc/mdq371. Review.

PMID:
20943644
13.

Consolidative surgery after targeted therapy for renal cell carcinoma.

Thomas AA, Campbell SC.

Urol Oncol. 2013 Aug;31(6):914-9. doi: 10.1016/j.urolonc.2011.10.005. Epub 2011 Dec 7. Review.

PMID:
22153755
14.

Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma.

Shinohara N, Abe T.

Int J Urol. 2015 Oct;22(10):888-97. doi: 10.1111/iju.12858. Epub 2015 Jul 5. Review.

15.

Successes and limitations of targeted therapies in renal cell carcinoma.

Pracht M, Berthold D.

Prog Tumor Res. 2014;41:98-112. doi: 10.1159/000355906. Epub 2014 Feb 17. Review.

PMID:
24727990
16.

Targeted therapy for locally advanced renal cell carcinoma.

Jonasch E, Tannir NM.

Target Oncol. 2010 Jun;5(2):113-8. doi: 10.1007/s11523-010-0147-4. Epub 2010 Jul 14. Review.

PMID:
20625844
17.

Update on targeted therapies for clear cell renal cell carcinoma.

Singer EA, Gupta GN, Srinivasan R.

Curr Opin Oncol. 2011 May;23(3):283-9. doi: 10.1097/CCO.0b013e32834479c0. Review.

19.

Treatment selection in metastatic renal cell carcinoma: more confusion or a path forward?

Hirsch BR, George DJ, Harrison MR.

Clin Adv Hematol Oncol. 2014 Mar;12(3):163-71. Review.

PMID:
24927264
20.

[Medical therapies for locally advanced/metastatic kidney cancer].

Afrit M, Yahyaoui Y, Bouzouita A, Hantous S, Labidi S, Chebil M, Ben Miled K, Escudier B, Boussen H.

Presse Med. 2015 Feb;44(2):135-43. doi: 10.1016/j.lpm.2014.07.020. Epub 2014 Dec 18. Review. French.

PMID:
25535168

Supplemental Content

Support Center